Neogen Corporation (NEOG) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-05-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-05-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-05-31..
Borrowing debt
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 793.70M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 3.35B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | (m) | (m) | $0.00 | $793.70M | (m) | (m) | $3.35B | (m) |
| 2026-02-28 | (m) | (m) | (m) | $793.30M | (m) | (m) | $3.36B | (m) |
| 2025-11-30 | (m) | (m) | (m) | $792.93M | (m) | (m) | $3.36B | (m) |
| 2025-08-31 | (m) | (m) | (m) | $792.53M | (m) | (m) | $3.38B | (m) |
| 2025-05-31 | (m) | (m) | $19.30M | $874.81M | (m) | $129.00M | $3.44B | (m) |
| 2025-02-28 | (m) | (m) | (m) | $890.61M | (m) | $127.70M | $4.04B | (m) |
| 2024-11-30 | (m) | (m) | (m) | $889.87M | (m) | $140.23M | $4.05B | (m) |
| 2024-08-31 | (m) | (m) | (m) | $889.13M | (m) | $120.48M | $4.50B | (m) |
| 2024-05-31 | (m) | (m) | $2.45M | $888.39M | (m) | $170.94M | $4.55B | (m) |
| 2024-02-29 | (m) | (m) | $2.52M | $887.65M | (m) | $168.45M | $4.58B | (m) |
| 2023-11-30 | (m) | (m) | $2.57M | $886.91M | (m) | $230.27M | $4.60B | (m) |
| 2023-08-31 | (m) | (m) | $2.64M | $886.18M | (m) | $239.26M | $4.56B | (m) |
| 2023-05-31 | (m) | (m) | (m) | $885.44M | (m) | $245.57M | $4.55B | (m) |
| 2023-02-28 | (m) | (m) | (m) | $884.70M | (m) | $183.21M | $4.51B | (m) |
| 2022-11-30 | (m) | (m) | (m) | $923.96M | (m) | $276.34M | $4.56B | (m) |
| 2022-05-31 | (m) | (m) | (m) | $0.00 | (m) | $381.05M | $992.93M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |